Bausch Health Companies (TSE:BHC) Shares Up 3% – Here’s What Happened

Bausch Health Companies Inc. (TSE:BHC) rose 3% during trading on Thursday . The stock traded as high as C$11.67 and last traded at C$11.61. 76,142 shares were traded during trading, a decline of 44% from the average session volume of 137,096 shares. The stock had previously closed at C$11.27.

Wall Street Analysts Forecast Growth

Separately, Evercore ISI raised Bausch Health Companies to a “hold” rating in a research note on Tuesday, October 15th.

Bausch Health Companies Price Performance

The company has a debt-to-equity ratio of 7,583.76, a current ratio of 1.19 and a quick ratio of 0.58. The firm has a market capitalization of C$4.18 billion, a price-to-earnings ratio of -6.50, a PEG ratio of 0.21 and a beta of 0.77. The business’s fifty day simple moving average is C$11.61 and its 200 day simple moving average is C$10.21.

Bausch Health Companies (TSE:BHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported C$1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of C$1.43 by C$0.10. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%. The company had revenue of C$3.42 billion for the quarter, compared to analysts’ expectations of C$3.36 billion. On average, research analysts forecast that Bausch Health Companies Inc. will post 5.5472637 EPS for the current year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.